Onderneming Sarepta Therapeutics Inc Nasdaq
Aandelen
US0023461041
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
21/06 | Sectorupdate: Gezondheidszorgaandelen winnen in de late namiddag | MT |
21/06 | S&P, Nasdaq dalen als Nvidia voor tweede dag daalt | RE |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
RNA-targeted Therapeutics, Gene Therapy and Other Genetic Therapeutic Modalities
100,0
%
| 933 | 100,0 % | 1 243 | 100,0 % | +33,26% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 933 | 100,0 % | 1 243 | 100,0 % | +33,26% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Douglas Ingram
CEO | Chief Executive Officer | 61 | 26-06-17 |
Ian Estepan
DFI | Director of Finance/CFO | 48 | 01-01-15 |
Bilal Arif
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 48 | 01-06-18 | |
Will Tilton
HRO | Human Resources Officer | - | - |
Alison Nasisi
HRO | Human Resources Officer | - | - |
Dallan Murray
PRN | Corporate Officer/Principal | - | 01-01-13 |
Diane Berry
PRN | Corporate Officer/Principal | - | 01-12-11 |
Ryan Brown
LAW | General Counsel | 46 | 01-01-18 |
Joseph Bratica
AUD | Comptroller/Controller/Auditor | 60 | 01-03-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Douglas Ingram
CEO | Chief Executive Officer | 61 | 26-06-17 |
M. Wilsey
CHM | Chairman | 71 | 31-03-09 |
Richard Barry
BRD | Director/Board Member | 65 | 02-06-15 |
Director/Board Member | 86 | 01-06-10 | |
Stephen Mayo
BRD | Director/Board Member | 62 | 16-11-21 |
Claude Nicaise
BRD | Director/Board Member | 71 | 02-06-15 |
Michael Chambers
BRD | Director/Board Member | - | 02-06-22 |
Kathryn Boor
BRD | Director/Board Member | 65 | 02-06-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 94 523 766 | 89 825 408 ( 95,03 %) | 0 | 95,03 % |
Bedrijfsgegevens
Sarepta Therapeutics, Inc.
215 First Street Suite 415
02142, Cambridge
+617 274 4000
http://www.sareptatherapeutics.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,20% | 121 mld. | |
+19,67% | 113 mld. | |
+17,15% | 26,02 mld. | |
-23,86% | 19,39 mld. | |
-19,91% | 15,91 mld. | |
-20,90% | 15,09 mld. | |
-46,14% | 15,06 mld. | |
+4,49% | 13,85 mld. | |
+116,20% | 10,8 mld. |
- Beurs
- Aandelen
- Koers SRPT
- Koers
- Onderneming Sarepta Therapeutics Inc